Pharmaceutical companies scored a major victory on Monday when a divided U.S. Supreme Court held that the industry’s sales representatives are not eligible for overtime pay.
The court, ruling 5-4 in Christopher v. SmithKline Beecham , found that the estimated 90,000 drug sales reps fell within the so-called “outside salesman” exemption from the minimum-wage and maximum-hours requirements of the Fair Labor Standards Act (FLSA).
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
